156 related articles for article (PubMed ID: 33929996)
21. The in Vitro and in Vivo Antitumor Activities of Tetracyclic Triterpenoids Compounds Actein and 26-Deoxyactein Isolated from Rhizome of Cimicifuga foetida L.
Wu D; Yao Q; Chen Y; Hu X; Qing C; Qiu M
Molecules; 2016 Jul; 21(8):. PubMed ID: 27483235
[TBL] [Abstract][Full Text] [Related]
22. Development of actein derivatives as potent anti-triple negative breast cancer agents.
Zhang H; Chen Y; Huang S; Xiao WW; Qiu MH; Shao LD; Chen CH; Li D
Bioorg Med Chem Lett; 2023 Jun; 89():129307. PubMed ID: 37121522
[TBL] [Abstract][Full Text] [Related]
23. Isobavachalcone isolated from
Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
[No Abstract] [Full Text] [Related]
24. Diallyl thiosulfinate enhanced the anti-cancer activity of dexamethasone in the side population cells of multiple myeloma by promoting miR-127-3p and deactivating the PI3K/AKT signaling pathway.
He W; Fu Y; Zheng Y; Wang X; Liu B; Zeng J
BMC Cancer; 2021 Feb; 21(1):125. PubMed ID: 33549034
[TBL] [Abstract][Full Text] [Related]
25. Dual PI3K-BRD4 Inhibitor SF1126 Inhibits Colorectal Cancer Cell Growth in Vitro and in Vivo.
Qin AC; Li Y; Zhou LN; Xing CG; Lu XS
Cell Physiol Biochem; 2019; 52(4):758-768. PubMed ID: 30933440
[TBL] [Abstract][Full Text] [Related]
26. Actein ameliorates hepatic steatosis and fibrosis in high fat diet-induced NAFLD by regulation of insulin and leptin resistant.
Chen HJ; Liu J
Biomed Pharmacother; 2018 Jan; 97():1386-1396. PubMed ID: 29156528
[TBL] [Abstract][Full Text] [Related]
27. Uncovering the action mechanism of homoharringtonine against colorectal cancer by using network pharmacology and experimental evaluation.
Qu M; Li J; Yuan L
Bioengineered; 2021 Dec; 12(2):12940-12953. PubMed ID: 34847838
[TBL] [Abstract][Full Text] [Related]
28. AMP-kinase inhibitor dorsomorphin reduces the proliferation and migration behavior of colorectal cancer cells by targeting the AKT/mTOR pathway.
Ghanaatgar-Kasbi S; Amerizadeh F; Rahmani F; Hassanian SM; Khazaei M; Ferns GA; Avan A
IUBMB Life; 2019 Dec; 71(12):1929-1936. PubMed ID: 31359579
[TBL] [Abstract][Full Text] [Related]
29. New potential beneficial effects of actein, a triterpene glycoside isolated from Cimicifuga species, in breast cancer treatment.
Yue GG; Xie S; Lee JK; Kwok HF; Gao S; Nian Y; Wu XX; Wong CK; Qiu MH; Lau CB
Sci Rep; 2016 Oct; 6():35263. PubMed ID: 27731376
[TBL] [Abstract][Full Text] [Related]
30. A steroidal saponin isolated from Allium chinense simultaneously induces apoptosis and autophagy by modulating the PI3K/Akt/mTOR signaling pathway in human gastric adenocarcinoma.
Xu J; Zhang M; Lin X; Wang Y; He X
Steroids; 2020 Sep; 161():108672. PubMed ID: 32485185
[TBL] [Abstract][Full Text] [Related]
31. Celastrol inhibits colorectal cancer cell proliferation and migration through suppression of MMP3 and MMP7 by the PI3K/AKT signaling pathway.
Bufu T; Di X; Yilin Z; Gege L; Xi C; Ling W
Anticancer Drugs; 2018 Jul; 29(6):530-538. PubMed ID: 29553945
[TBL] [Abstract][Full Text] [Related]
32. Hypericum androsaemum water extract inhibits proliferation in human colorectal cancer cells through effects on MAP kinases and PI3K/Akt pathway.
Xavier CP; Lima CF; Fernandes-Ferreira M; Pereira-Wilson C
Food Funct; 2012 Aug; 3(8):844-52. PubMed ID: 22596086
[TBL] [Abstract][Full Text] [Related]
33. Betulin terpenoid targets OVCAR-3 human ovarian carcinoma cells by inducing mitochondrial mediated apoptosis, G2/M phase cell cycle arrest, inhibition of cell migration and invasion and modulating mTOR/PI3K/AKT signalling pathway.
Yang Q; Fei Z; Huang C
Cell Mol Biol (Noisy-le-grand); 2021 Sep; 67(2):14-19. PubMed ID: 34817343
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression.
Li Y; Zeng C; Hu J; Pan Y; Shan Y; Liu B; Jia L
J Hematol Oncol; 2018 Jul; 11(1):89. PubMed ID: 29970122
[TBL] [Abstract][Full Text] [Related]
35. Effect of AMPK/Akt/mTOR pathway on cytokine-induced killer cells immunotherapy on colorectal cancer cells.
Shi J; Wu J; Ni H; Zhan X; Zhang L; Zhang Z
J BUON; 2019; 24(1):116-122. PubMed ID: 30941959
[TBL] [Abstract][Full Text] [Related]
36. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
37. P300 increases CSNK2A1 expression which accelerates colorectal cancer progression through activation of the PI3K-AKT-mTOR axis.
Liu J
Exp Cell Res; 2023 Sep; 430(1):113694. PubMed ID: 37391010
[TBL] [Abstract][Full Text] [Related]
38. The PI3K/Akt pathway is involved in procyanidin-mediated suppression of human colorectal cancer cell growth.
Choy YY; Fraga M; Mackenzie GG; Waterhouse AL; Cremonini E; Oteiza PI
Mol Carcinog; 2016 Dec; 55(12):2196-2209. PubMed ID: 26774105
[TBL] [Abstract][Full Text] [Related]
39. Dual mTOR/PI3K inhibitor NVP‑BEZ235 arrests colorectal cancer cell growth and displays differential inhibition of 4E‑BP1.
Alqurashi N; Hashimi SM; Alowaidi F; Ivanovski S; Wei MQ
Oncol Rep; 2018 Aug; 40(2):1083-1092. PubMed ID: 29845289
[TBL] [Abstract][Full Text] [Related]
40. Actein inhibits glioma growth via a mitochondria-mediated pathway.
Yuan LQ; Chen YM; Sun C; Wang ZY; Wang DL; Lan Q
Cancer Biomark; 2017; 18(4):329-338. PubMed ID: 28128733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
